MedTrace Logo

Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery

NCT07064135 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this clinical trial is to find out if patients who receive extra support stay on their cholesterol-lowering therapy and therefore have lower cholesterol levels after 4 months. Extra support means regular phone calls and close monitoring before and after carotid artery surgery. The study compares this approach to usual care.

Participants will:

Be randomly assigned to either standard care or extra support for 4 months. Receive cholesterol-lowering treatment and attend follow-up visits.

Conditions

  • Dyslipidaemias
  • Carotid Artery Stenoses

Interventions

BEHAVIORAL

Prompt Medication Adjustment and Intensive Follow-up

Participants receive prompt adjustment of lipid-lowering therapy perioperatively and 6-8 weeks after carotid endarterectomy to achieve guideline-recommended LDL-C targets, combined with intensive follow-up visits and laboratory monitoring. Intensive follow-up visits and laboratory monitoring of lipid parameters are performed at 6-8 weeks and again at 12-16 weeks postoperatively to optimize lipid management.

OTHER

Standard Care

Participants receive standard postoperative care according to guidelines, including lipid management and routine follow-up without additional early intervention or intensive monitoring. Lipid parameters are assessed only once at 12-16 weeks postoperatively.

Sponsors & Collaborators

  • Johannes Kepler University of Linz

    collaborator OTHER

  • Barmherzige Brüder Linz

    lead OTHER

Principal Investigators

  • Martin Clodi, Professor, MD · Konventspital Barmherzige Brüder Linz

  • Juergen Falkensammer, Associate Professor, MD · Konventspital Barmherzige Brüder Linz

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07064135 on ClinicalTrials.gov